81
IRUS Total
Downloads
  Altmetric

Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study

File Description SizeFormat 
art%3A10.1186%2Fs12974-017-0812-y.pdfPublished version1.41 MBAdobe PDFView/Open
Title: Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study
Authors: Farina, G
Magliozzi, R
Pitteri, M
Reynolds, R
Rossi, S
Gajofatto, A
Benedetti, MD
Facchiano, F
Monaco, S
Calabrese, M
Item Type: Journal Article
Abstract: Background: Although IgG oligoclonal bands (OCBs) in the cerebrospinal fluid (CSF) are a frequent phenomenon in multiple sclerosis (MS) patients, their relationship with grey matter lesions, intrathecal/meningeal inflammation and clinical evolution has not been clarified yet. The aim of our study was to assess the relationship between the OCBs, the inflammatory/neurodegenerative CSF profile at diagnosis, the cortical lesion load and the clinical evolution after 10 years. Methods: This is a 10-year observational, cross-sectional study based on a combined MRI, cognitive and CSF profiling of the examined patients. Forty consecutive OCB-negative (OCB−) and 50 OCB-positive (OCB+) MS patients were included in this study. Both groups had mean disease duration of 10 years and were age and gender matched. Each patient underwent neurological and neuropsychological evaluation and 3-T MRI. Analysis of the presence and levels of 28 inflammatory mediators was performed in the CSF obtained from 10 OCB− MS, 11 OCB+ MS and 10 patients with other neurological conditions. Results: Increased number of CLs was found in OCB+ compared to OCB− patients (p < 0.0001), whereas no difference was found in white matter lesion (WML) load (p = 0.36). The occurrence of OCB was also associated with increased levels of neurofilament light chains and of several inflammatory mediators linked to B lymphocyte activity and lymphoid-neogenesis (CXCL13, CXCL12, CXCL10, TNFSF13, TNFSF13B, IL6, IL10) and other pro-inflammatory molecules, such as IFN-γ, TNF, MMP2, GM-CSF, osteopontin and sCD163. Finally, the occurrence of OCB was found associated with poor prognosis, from both physical and cognitive points of view. Conclusions: OCB at MS onset are associated with more severe GM pathology and with a more severe physical disability and cognitive impairment after 10 years. Increased levels of cytokines linked to B cell activation, lymphoid-neogenesis, and pro-inflammatory immune response in the CSF of OCB+ patients support the hypothesis of crucial role played by compartmentalized, intrathecal B cell response in the pathogenesis of CLs and OCB production.
Issue Date: 21-Feb-2017
Date of Acceptance: 2-Feb-2017
URI: http://hdl.handle.net/10044/1/45738
DOI: https://dx.doi.org/10.1186/s12974-017-0812-y
ISSN: 1742-2094
Publisher: BIOMED CENTRAL LTD
Journal / Book Title: JOURNAL OF NEUROINFLAMMATION
Volume: 14
Issue: 1
Copyright Statement: © 2017 The Author(s). Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Sponsor/Funder: Multiple Sclerosis Society
The Progressive MS Alliance
Funder's Grant Number: 007/14
PA 0124 MS Alliance
Keywords: Science & Technology
Life Sciences & Biomedicine
Immunology
Neurosciences
Neurosciences & Neurology
CSF
MRI
Oligoclonal bands
IgG
Multiple sclerosis
OCB
Cytokines
Grey matter
Neuroinflammation
Neurodegeneration
CENTRAL-NERVOUS-SYSTEM
B-CELL FOLLICLES
CEREBROSPINAL-FLUID
MENINGEAL INFLAMMATION
MATTER DAMAGE
CXCL13
DISABILITY
PATHOLOGY
DEMYELINATION
EXPRESSION
Neurology & Neurosurgery
1103 Clinical Sciences
1109 Neurosciences
1107 Immunology
Publication Status: Published
Open Access location: https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0812-y
Article Number: ARTN 40
Appears in Collections:Department of Medicine (up to 2019)